Hint mode is switched on Switch off
For swift navigation between sections

International bonds: Teva Pharmaceutical Industries, FRN 19dec2011, USD
US88166BAA89

  • Placement amount
    500,000,000 USD
  • Outstanding amount
    500,000,000 USD
  • Minimum Settlement Amount
    2,000 USD
  • ISIN
    US88166BAA89
  • Common Code
    051989694
  • CFI
    DBFGGR
  • FIGI
    BBG0000X6K50
  • Ticker
    TEVA F 12/19/11

Find Any Data on Any Bond in Just One Click

Full data on over 500,000 bonds and stocks worldwide

Powerful bond screener

Ratings from the top 3 global ratings agencies, plus over 70 local ones

Over 300 pricing sources from the OTC market and world stock exchanges

User-friendly and intuitive across multiple platforms

Get access

Files

Prospectus

Trading chart

Stock exchange selection
Stock exchange selection
More about Cbonds Estimation
Bond is not traded; the issue is redeemed
Data display in a chart | table
Data display in a chart | table
Work with the chart: switching the price, period, issue comparison
Work with the chart: switching the price, period, issue comparison
Download the chart in a convenient format
Customize fields in the table
Found:
Show all fields
from
to
ADD-IN
Cbonds add-in API
bond data api
* Data is not available within the selected subscription
Latest data on

Issue information

Profile
Teva Pharmaceutical Industries Ltd., is a global pharmaceutical company. The Company develops, manufactures, and markets generic and branded human pharmaceuticals as well as active pharmaceutical ingredients.
Volume
  • Placement amount
    500,000,000 USD
  • Outstanding amount
    500,000,000 USD
Nominal
  • Minimum Settlement Amount
    2,000 USD
  • Outstanding face value
    *** USD
  • Integral multiple
    *** USD
  • Nominal
    1,000 USD

Cash flow parameters

  • Reference rate
    3M LIBOR USD
  • Coupon Rate
    ***
  • Day count fraction
    ***
  • Interest Accrual Date
    ***
  • Coupon frequency
    *** time(s) per year
  • Payment currency
    ***
  • Maturity date
    ***

Early redemption terms

***

Find Any Data on Any Bond in Just One Click

Full data on over 500,000 bonds and stocks worldwide

Powerful bond screener

Ratings from the top 3 global ratings agencies, plus over 70 local ones

Over 300 pricing sources from the OTC market and world stock exchanges

User-friendly and intuitive across multiple platforms

Get access

Placement

  • Placement method
    Open subscription
  • Placement
    ***
  • Initial issue price (yield)
  • Geographic breakdown
    ***
  • Investor breakdown
    ***
Participants
  • Bookrunner
    ***, ***, ***

Conversion and exchange

  • Conversion terms
    ***

Additional information

***

Latest issues

Show all

News

01/08/2022 S&P Global Ratings revised outlook on Teva Pharmaceutical Industries to positive and affirmed at "BB-" (Foreign Currency LT) credit rating
01/08/2022 S&P Global Ratings revised outlook on Teva Pharmaceutical Industries to positive and affirmed at "BB-" (Local Currency LT) credit rating
30/07/2022 S&P: Teva Pharmaceutical Industries Ltd. Outlook Revised To Positive From Stable On Opioid Settlement, Rating Affirmed (Rating action commentary)
26/07/2022 Teva Pharmaceutical Industries: Results Of Operations And Financial Condition, Financial Statements And Exhibits
23/06/2022 Teva Pharmaceutical Industries: Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Submission Of Matters To A Vote Of Security Holders, Financial Statements And Exhibits
All organization news

Identifiers

  • ISIN
    ***
  • CUSIP
    ***
  • CUSIP 144A
    ***
  • Common Code
    051989694
  • CFI
    DBFGGR
  • FIGI
    BBG0000X6K50
  • Ticker
    TEVA F 12/19/11
  • Type of security by CBR
    ***

Bond classification

  • Registered
  • Coupon bonds
  • Variable rate
  • Amortization
  • Callable
  • CDO
  • Convertible
  • Dual currency bonds
  • For qualified investors (CIS region)
  • Foreign bonds
  • Green bonds
  • Guaranteed
  • Inflation-linked principal
  • Supranational bond issues
  • Inflation-linked coupon
  • Mortgage bonds
  • Perpetual
  • Payment-in-kind
  • Non-Marketable Securities
  • Redemption Linked
  • Restructuring
  • Retail bonds
  • Covered
  • Securitization
  • Structured product
  • Commercial Bonds
  • Subordinated
  • Sukuk
  • Trace-eligible
Show more Hide

Restructuring

***

IFRS/US GAAP reports

2022
I q eng
II q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
IV q eng
2016
IV q eng
2015
IV q eng
2014
IV q eng
Show all Hide
Registration is required to get access.